Track topics on Twitter Track topics that are important to you
India, in the Asian subcontinent is the world’s fourth largest producer of pharmaceuticals, and is thought as one of the most promising biotech markets in the world. Several important steps ...
To view our most recent articles on Lice Treatment please go to: http://www.bioportfolio.com/news/article/987636/Pediculosis-Louse-Lice-Treatment.html
DelveInsight's, NeurofibromaPipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Neurofibroma. The DelveInsight'sReport covers...
India’s Union for Affordable Cancer Treatment (UACT), along with 56 other organizations, has requested…
Johnson & Johnson and India's Institute of Microbial Technology, part of the Council of Scientific and Industrial Research, w -More-
Mylan's antiretroviral drug Avonza for first-line treatment of HIV/AIDS gained approval for release in India. -More-
The "world's heaviest woman" has shed half her weight—around a quarter of a tonne—in the two months she's been in India for treatment, doctors said.
Healthcare in India is largely perceived as a science of treatment and blissfully ignores it as a science of prevention.
Doctors in India have publicly condemned the payment of commissions to fellow doctors who refer patients to them for diagnosis, treatment, or surgery, and are seeking government intervention to curb.....
Over the last decade, pharmaceutical companies in India has witnessed tremendous growth and advances. With pharmaceutical research in India on the rise and advances in health, medical, and biotechnolo...
Neurofibromas are benign peripheral nerve tumors driven by NF1 loss in Schwann cells (SCs). Macrophages are abundant in neurofibromas, and macrophage targeted interventions may have therapeutic potent...
Solitary neurofibroma originating from the external nose is extremely rare, and to our knowledge, only 3 cases have been reported so far in English literatures. It may originate from the ophthalmic (V...
In India, migrant status, tribal affiliation and poverty render tribal migrants more vulnerable than any other group which leads to high treatment costs and the risk of low access to health care.
Bedaquiline (BDQ) has been approved in India for the treatment of multidrug-resistant tuberculosis (MDR-TB), but is currently recommended for MDR-TB patients who have failed initial treatment with sta...